USD 102.17
(1.31%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 124.13 Million USD | -25.78% |
2022 | 167.25 Million USD | -34.09% |
2021 | 253.77 Million USD | 10.62% |
2020 | 229.41 Million USD | 212.28% |
2019 | 73.46 Million USD | 326.58% |
2018 | 17.22 Million USD | -56.79% |
2017 | 39.86 Million USD | 77.3% |
2016 | 22.48 Million USD | 1094.58% |
2015 | 1.88 Million USD | -29.7% |
2014 | 2.67 Million USD | 0.0% |
2013 | - USD | -100.0% |
2012 | 16.25 Million USD | -34.89% |
2011 | 24.95 Million USD | -37.65% |
2010 | 40.02 Million USD | -4.36% |
2009 | 41.85 Million USD | -25.37% |
2008 | 56.07 Million USD | 12.93% |
2007 | 49.65 Million USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 138.39 Million USD | -19.97% |
2024 Q2 | 38.35 Million USD | -100.0% |
2024 Q3 | 38.6 Million USD | 0.0% |
2023 Q2 | 121.91 Million USD | -19.52% |
2023 Q3 | 205.54 Million USD | 68.6% |
2023 Q4 | 124.13 Million USD | -39.61% |
2023 FY | 124.13 Million USD | -25.78% |
2023 Q1 | 151.48 Million USD | -9.43% |
2022 Q3 | 200.72 Million USD | -14.47% |
2022 Q2 | 234.68 Million USD | -20.49% |
2022 FY | 167.25 Million USD | -34.09% |
2022 Q1 | 295.17 Million USD | 16.32% |
2022 Q4 | 167.25 Million USD | -16.68% |
2021 Q4 | 253.77 Million USD | -0.18% |
2021 Q3 | 254.21 Million USD | 11.47% |
2021 Q2 | 228.05 Million USD | -0.61% |
2021 Q1 | 229.46 Million USD | 0.02% |
2021 FY | 253.77 Million USD | 10.62% |
2020 Q4 | 229.41 Million USD | 145.27% |
2020 FY | 229.41 Million USD | 212.28% |
2020 Q1 | 72.75 Million USD | -0.97% |
2020 Q3 | 93.53 Million USD | 30.42% |
2020 Q2 | 71.72 Million USD | -1.42% |
2019 Q3 | 71.8 Million USD | 46.07% |
2019 Q2 | 49.16 Million USD | 69.2% |
2019 FY | 73.46 Million USD | 326.58% |
2019 Q1 | 29.05 Million USD | 68.7% |
2019 Q4 | 73.46 Million USD | 2.31% |
2018 Q4 | 17.22 Million USD | -82.58% |
2018 Q2 | 99.35 Million USD | 152.2% |
2018 Q1 | 39.39 Million USD | -1.16% |
2018 Q3 | 98.89 Million USD | -0.47% |
2018 FY | 17.22 Million USD | -56.79% |
2017 Q3 | 40.37 Million USD | -1.5% |
2017 FY | 39.86 Million USD | 77.3% |
2017 Q4 | 39.86 Million USD | -1.27% |
2017 Q2 | 40.98 Million USD | 87.35% |
2017 Q1 | 21.87 Million USD | -2.69% |
2016 FY | 22.48 Million USD | 1094.58% |
2016 Q4 | 22.48 Million USD | -1.06% |
2016 Q2 | 40.17 Million USD | 29.31% |
2016 Q1 | 31.07 Million USD | 1550.9% |
2016 Q3 | 22.72 Million USD | -43.44% |
2015 Q4 | 1.88 Million USD | -12.95% |
2015 FY | 1.88 Million USD | -29.7% |
2015 Q1 | 2.42 Million USD | -9.41% |
2015 Q3 | 2.16 Million USD | -11.39% |
2015 Q2 | 2.44 Million USD | 0.62% |
2014 Q1 | - USD | 0.0% |
2014 Q4 | 2.67 Million USD | -8.51% |
2014 Q2 | - USD | 0.0% |
2014 FY | 2.67 Million USD | 0.0% |
2014 Q3 | 2.92 Million USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q1 | - USD | -100.0% |
2013 Q2 | - USD | 0.0% |
2013 FY | - USD | -100.0% |
2012 FY | 16.25 Million USD | -34.89% |
2012 Q4 | 16.25 Million USD | -20.73% |
2012 Q3 | 20.5 Million USD | -6.82% |
2012 Q2 | 22 Million USD | -17.76% |
2012 Q1 | 26.75 Million USD | 7.18% |
2011 Q2 | 34.02 Million USD | 18.76% |
2011 Q3 | 28.4 Million USD | -16.53% |
2011 FY | 24.95 Million USD | -37.65% |
2011 Q4 | 24.95 Million USD | -12.13% |
2011 Q1 | 28.65 Million USD | -28.42% |
2010 Q1 | 44.81 Million USD | 7.09% |
2010 Q2 | 44.81 Million USD | 0.0% |
2010 FY | 40.02 Million USD | -4.36% |
2010 Q4 | 40.02 Million USD | -9.34% |
2010 Q3 | 44.15 Million USD | -1.49% |
2009 Q3 | 49.78 Million USD | -8.28% |
2009 FY | 41.85 Million USD | -25.37% |
2009 Q2 | 54.27 Million USD | 0.0% |
2009 Q4 | 41.85 Million USD | -15.93% |
2008 FY | 56.07 Million USD | 12.93% |
2008 Q4 | 56.07 Million USD | 0.0% |
2007 FY | 49.65 Million USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 1.34 Billion USD | 90.754% |
AirSculpt Technologies, Inc. | 69.5 Million USD | -78.599% |
Amedisys, Inc. | 346.76 Million USD | 64.203% |
American Oncology Network, Inc. | 120.44 Million USD | -3.062% |
Astrana Health, Inc. | 296.26 Million USD | 58.1% |
Aveanna Healthcare Holdings Inc. | 1.27 Billion USD | 90.274% |
IMAC Holdings, Inc. | - USD | -Infinity% |
biote Corp. | 106.63 Million USD | -16.414% |
Cryo-Cell International, Inc. | 9.28 Million USD | -1237.345% |
Cross Country Healthcare, Inc. | 2.66 Million USD | -4561.359% |
COMPASS Pathways plc | 28.75 Million USD | -331.658% |
DocGo Inc. | 15.16 Million USD | -718.709% |
The Ensign Group, Inc. | 1.78 Billion USD | 93.045% |
Healthcare Services Group, Inc. | 11.23 Million USD | -1004.869% |
InnovAge Holding Corp. | 100.49 Million USD | -23.519% |
Assure Holdings Corp. | 505 Thousand USD | -24480.594% |
The Joint Corp. | 2 Million USD | -6106.6% |
LifeStance Health Group, Inc. | 280.28 Million USD | 55.712% |
Mobile-health Network Solutions Class A Ordinary Shares | 381.43 Thousand USD | -32443.08% |
ModivCare Inc. | 983.75 Million USD | 87.382% |
NewGenIvf Group Limited | 118.97 Thousand USD | -104231.016% |
Novo Integrated Sciences, Inc. | 1.75 Million USD | -6958.509% |
Option Care Health, Inc. | 1.05 Billion USD | 88.252% |
P3 Health Partners Inc. | 108.31 Million USD | -14.599% |
P3 Health Partners Inc. | 108.31 Million USD | -14.599% |
The Pennant Group, Inc. | 312.51 Million USD | 60.279% |
Surgery Partners, Inc. | 2.03 Billion USD | 93.896% |
Syra Health Corp. Class A Common Stock | - USD | -Infinity% |
Talkspace, Inc. | - USD | -Infinity% |
Talkspace, Inc. | - USD | -Infinity% |
The Oncology Institute, Inc. | 86.82 Million USD | -42.966% |
The Oncology Institute, Inc. | 86.82 Million USD | -42.966% |